We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content. Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
(J&J/Janssen Biotech) Jan 19, 2017 - First therapy specifically indicated for this rare blood cancer; represents fifth indication for IMBRUVICA in the U.S.
(AACR) Jan 20, 2017 - Pazdur will oversee the first disease area (oncology) at the FDA to have a coordinated clinical review of drugs, biologics and devices across the agency’s three medical product centers.
(FDA.gov) Jan 19, 2017 - The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.
(TheWeek [UK]) Jan 20, 2017 - A simple scan could help doctors catch and diagnose prostate cancer without the need for biopsies, according to a new study.
(ASCO in Action) Jan 19, 2017 - Statement by Clifford A. Hudis, MD, FACP, FASCO, Chief Executive Officer of ASCO.
(Georgia State University) Jan 19, 2017 - Administering chemotherapy to African-American breast cancer patients prior to surgery could improve their prognosis and survival rates from the disease, according to a new study.
(New York Times) Jan 12, 2017 - A House vote on Friday will come after the Senate approved a measure that would allow Republicans to speedily gut the Affordable Care Act with no threat of a filibuster.
(ASCO in Action) Jan 19, 2017 - On January 17, the Food and Drug Administration (FDA) outlined the criteria companies must meet to get a biologic deemed interchangeable with its branded counterpart in draft guidance.
(Mayo Clinic) Jan 19, 2017 - Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer. In a new paper published this week in Cancer Cell, Mayo Clinic researchers provide genetic evidence that Ect2 drives lung adenocarcinoma tumor formation.
(ASCO in Action) Jan 19, 2017 - On January 18, 2017, the Department of Health and Human Services (HHS), along with more than a dozen other federal agencies, finalized updates to the Common Rule, which protects human subjects in biomedical research.